Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Angina at Rest

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Angina at Rest in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, CM; Jia, XQ; Qin, J; Zhang, L1
Elisaf, M; Goudevenos, JA; Michalis, L; Sideris, DA; Stroumbis, CS; Tambaki, AP; Tselepis, AD; Tsoukatos, DC1
Kendrew, PJ; Nidorf, SM; Strophair, J; Sturm, M; Taylor, RR1
Hansen, BF; Hansen, JF1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Angina at Rest

ArticleYear
[Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology].
    Ugeskrift for laeger, 1987, Nov-02, Volume: 149, Issue:45

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Calcium Channel Blockers; Coronary Angiography; Coronary Vessels; Death, Sudden; Endoscopy; Heparin; Humans; Myocardial Infarction; Platelet Activating Factor

1987

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Angina at Rest

ArticleYear
[Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2012, Volume: 24, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coronary Disease; Double-Blind Method; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Prospective Studies; Ticlopidine; Tissue Plasminogen Activator; von Willebrand Factor

2012

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Angina at Rest

ArticleYear
Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
    Cardiovascular research, 1999, Volume: 43, Issue:1

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Abciximab; Aged; Aged, 80 and over; Analysis of Variance; Angina, Unstable; Antibodies, Monoclonal; Case-Control Studies; Cholesterol; Cholesterol, HDL; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Triglycerides

1999
Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina.
    Cardiovascular research, 1989, Volume: 23, Issue:4

    Topics: Adenosine Diphosphate; Aged; Angina Pectoris; Angina, Unstable; Collagen; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Thromboxane B2

1989